======= APOM ======= == Gene Information == * **Official Symbol**: APOM * **Official Name**: apolipoprotein M * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55937|55937]] * **UniProt**: [[https://www.uniprot.org/uniprot/O95445|O95445]] * **Interactions**: [[https://thebiogrid.org/search.php?search=APOM&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20APOM|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606907|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Probably involved in lipid transport. Can bind sphingosine-1-phosphate, myristic acid, palmitic acid and stearic acid, retinol, all-trans-retinoic acid and 9-cis-retinoic acid. {ECO:0000269|PubMed:17525477, ECO:0000269|PubMed:19733574}. |ApoM| |negative regulation of plasma lipoprotein oxidation| |discoidal high-density lipoprotein particle| |regulation of plasma lipoprotein oxidation| |spherical high-density lipoprotein particle| |high-density lipoprotein particle clearance| |high-density lipoprotein particle assembly| |low-density lipoprotein particle| |reverse cholesterol transport| |high-density lipoprotein particle remodeling| |antioxidant activity| |very-low-density lipoprotein particle| |high-density lipoprotein particle| |cholesterol efflux| |plasma lipoprotein particle assembly| |plasma lipoprotein particle remodeling| |protein-lipid complex remodeling| |protein-containing complex remodeling| |protein-lipid complex assembly| |lipid transporter activity| |plasma lipoprotein particle clearance| |plasma lipoprotein particle organization| |protein-lipid complex subunit organization| |cholesterol transport| |sterol transport| |regulation of plasma lipoprotein particle levels| |cholesterol homeostasis| |sterol homeostasis| |cellular oxidant detoxification| |cellular detoxification| |retinoid metabolic process| |phospholipid binding| |diterpenoid metabolic process| |lipoprotein metabolic process| |terpenoid metabolic process| |detoxification| |lipid homeostasis| |isoprenoid metabolic process| |response to glucose| |organic hydroxy compound transport| |response to hexose| |response to monosaccharide| |response to carbohydrate| |cellular response to toxic substance| |lipid transport| |lipid localization| |extracellular structure organization| |response to toxic substance| |negative regulation of cellular component organization| |cellular lipid metabolic process| |chemical homeostasis| |negative regulation of multicellular organismal process| |lipid metabolic process| |response to oxygen-containing compound| |protein-containing complex assembly| |homeostatic process| |protein-containing complex subunit organization| |extracellular region| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp73|LJH685 5μM R02 exp73]]|-2.07| |[[:results:exp141|Nifurtimox 1μM R03 exp141]]|1.72| |[[:results:exp124|GSK343 3μM R03 exp124]]|1.8| |[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|1.95| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16682 * **Expression level (log2 read counts)**: 1.84 {{:chemogenomics:nalm6 dist.png?nolink |}}